Cancer body (2) | ![]() |
Cervical cancer (8) | ![]() |
Myeloma (3) | ![]() |
against several conditions, including multiple myeloma. But GSK, of London, has scuttled development of SRT501, it confirmed to the patient website Myeloma Beacon last week.
Instead, the company is focusing on other chemicals thought to activate the same biological pathway as resveratrol.
Some users of glyphosate were observed to have a higher risk of multiple myeloma, a cancer affecting bone marrow,
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011